文献速递心外重症与机械循环支持

左心室辅助装置试验中卒中复杂格局的综述

A Review of the Complex Landscape of Stroke in Left Ventricular Assist Device Trials.
PubMed 文献 · Ann Thorac Surg · 2020-04-11

本文综述了五项主要左心室辅助装置(LVAD)随机对照试验中卒中定义与事件率的差异,指出定义异质性、病因评估非标准化、严重程度分类简化及事件率报告不一致等问题妨碍了设备间比较与预防策略设计,并提出未来试验应标准化卒中定义、整合神经科医生、采用多模态病因评估及NIHSS量表。

要点

  • LVAD试验间卒中定义和事件率报告存在方法学差异,限制设备比较。
  • 卒中病因评估非标准化且严重程度分类过度简化。
  • 建议未来试验标准化卒中定义并整合神经科医生参与裁定。

核心结论

  • LVAD临床试验中卒中事件比较受方法学变异混杂,限制设备比较和预防策略设计。

研究设计与样本

  • 综述五项主要LVAD随机对照试验,抽象比较卒中定义和事件率,识别方法学局限并提出改进建议。

主要发现

  • 卒中定义存在异质性,病因评估非标准化,严重程度分类过度简化,事件率报告因死亡或移植时数据删失而不一致。

关键数值与推荐

  • 未来试验应使用标准化卒中定义并定义卒中亚型。
  • 确保神经科医生参与研究设计和事件裁定。
  • 采用多模态技术进行更彻底的卒中病因评估。
  • 采用美国国立卫生研究院卒中量表(NIHSS)定义卒中严重程度。

临床怎么用

  • 临床解读LVAD卒中数据时需考虑试验间定义和报告差异,未来研究应遵循标准化建议。

局限性

  • 综述基于五项试验的抽象数据,方法学变异限制设备间比较。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite innovations in left ventricular assist device (LVAD) technology, stroke remains a leading cause of morbidity and mortality in this population. Major clinical trials of LVAD have used various definitions and approaches to measuring stroke outcomes, which may limit comparison of stroke risk between different devices. METHODS: Data from the five major LVAD randomized, controlled, trials were abstracted to compare definitions of stroke (composite, ischemic, hemorrhagic, and disabling) and stroke event rates across trials. Methodologic limitations and suggestions to improve research and clinical practices for stroke and LVAD were identified. RESULTS: Comparison of stroke events across LVAD clinical trials is confounded by methodologic variability, including heterogeneity in stroke definitions, nonstandardized evaluation of stroke etiology, oversimplification of stroke severity classification, and inconsistent event rate reporting due to data censoring at the time of death or transplant. Variability in the study of stroke in LVAD patients limits the ability to compare devices and design prevention strategies to mitigate stroke risk. CONCLUSIONS: Based on this review, we propose that future clinical trials (1) utilize standardized stroke definitions and define stroke subtypes; (2) ensure that neurologists are integrated in study design and event adjudication; (3) include more thorough evaluations of stroke etiology using multimodality techniques; and (4) adopt the National Institutes of Health Stroke Scale to define stroke severity.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Mai X, Reyentovich A, Norcliffe-Kaufmann L, et al. A Review of the Complex Landscape of Stroke in Left Ventricular Assist Device Trials. Ann Thorac Surg. 2020. PMID: 32289297. doi:10.1016/j.athoracsur.2020.03.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。